Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Everest Medical

This article was originally published in The Gray Sheet

Executive Summary

Receives $800,000 equity investment from a private investor through the sale of 290,909 units at $2.75 each. The units consist of one share of unregistered common stock and one warrant to purchase a share of unregistered common stock for $3.50. The company had announced Jan. 21 that it was seeking financing from "numerous corporate and private sources" to continue operations ("The Gray Sheet" Feb. 1, p. 14). Everest Medical Chairman Michael Hollenhorst says in a Feb. 8 release that the recent investment "provides us with necessary working capital which will help us to cover operating expenses as we roll out our laparoscopic surgical scissors and forceps." The company "will require additional capital, which is being sought from various sources." The minimally invasive surgery products manufacturer says it has taken steps to "further reduce" its operating expenses and expects to make "additional spending and staff reductions." The company believes the reductions can be made "without significantly jeopardizing" sales and development activities. The firm also announced Feb. 8 that it has received notice from its Japanese distributor, Koshin International, that Japan's Ministry of Health has granted approval for Koshin to commence promotion and sales of Everest Medical's Evershears bipolar laparoscopic scissors in Japan.

You may also be interested in...



US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

UsernamePublicRestriction

Register

MT000198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel